drugset / Trial / NCT02179658
A Study to Compare Safety and Efficacy of OPT-80(Fidaxomicin) With Vancomycin in Subjects With Clostridium Difficile-associated Diarrhea (CDAD)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The primary objective of this study is to investigate the safety and efficacy of OPT-80 versus vancomycin in subjects with Clostridium difficile-associated diarrhea (CDAD).
Timeline
- Start
- 2014-06-23
- Primary completion
- 2016-09-08
- Completion
- 2016-09-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fidaxomicin | Other / unclassified | 200 mg | Oral |
| Comparator | Vancomycin | Other / unclassified | 125 mg | Oral |